United States: FDA Changes Direction In Final CDS Guidance - Akin Gump Strauss Hauer & Feld LLP

Mondaq

06 Oct 2022 0 shares 1 views

United States: FDA Changes Direction In Final CDS Guidance - Akin Gump Strauss Hauer & Feld LLP

Mondaq

Published 06 Oct 2022

On September 28, 2022, the Food and Drug Administration (FDA) released the final version of its policy on Clinical Decision Support (CDS) software ("Final Guidance").

Full Article

United States: Commerce Department Publishes Updated Guidance On Antiboycott Enforcement Policies - Akin Gump Strauss Hauer & Feld LLP

Mondaq 24 Oct 2022

U.S. antiboycott laws, which are divided into two separate regimes administered by the U.S. Department of Commerce and the U.S...

United States: BIS Announces Significant Changes To How It Administers Unverified And Entity Lists - Akin Gump Strauss Hauer & Feld LLP
Mondaq 12 Oct 2022
United States: IRS Issues Request For Public Comment On Clean Energy And Climate Provisions Included In Inflation Reduction Act - Akin Gump Strauss Hauer & Feld LLP
Mondaq 07 Oct 2022
United States: As ‘Skinny' FDA User Fee Reauthorizations Cross Finish Line, Congress Prepares To Revisit FDA Policy Riders In Lame Duck Session - Akin Gump Strauss Hauer & Feld LLP
Mondaq 06 Oct 2022
United States: Fourth (and Final?) Act In The Kabab-Ji Saga—What Law Governs The Arbitration Agreement (Law Of The Seat Or Law Of The Underlying Contract)? - Akin Gump Strauss Hauer & Feld LLP
Mondaq 05 Oct 2022

United States: FDA Changes Direction In Final CDS Guidance - Akin Gump Strauss Hauer & Feld LLP

United States: FDA Changes Direction In Final CDS Guidance - Akin Gump Strauss Hauer & Feld LLP

You might like

Related news coverage

United States: Commerce Department Publishes Updated Guidance On Antiboycott Enforcement Policies - Akin Gump Strauss Hauer & Feld LLP

Advertisement